Home › Funds › Prosight Management, LP › BSX

Prosight Management, LP position in BSX

BOSTON SCIENTIFIC CORP · Health Care

Prosight Management, LP reported holding 550,000 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$24.0M, representing 4.66% of its reported portfolio and ranking #7 among its reported holdings. Prosight Management, LP has disclosed BSX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)550.00K sh
Reported value held$24.01M
Portfolio Weight4.66%
First reportedQ3 2025
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Prosight Management, LP's BSX position evolved

Prosight Management, LP first disclosed a stake in BSX in Q3 2025 at 76,100 shares (US$7.4M). The position peaked in Q2 2026 at 1,270,273 shares, worth US$54.2M. Across 5 filings, Prosight Management, LP increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 550,000 shares valued at US$24.0M — a reduction of -720,273 shares quarter over quarter.. Notable position changes include a 176% increase in Q4 2025 (shares fell 34% over the following quarter), a 279% increase in Q1 2026 (shares fell 32% over the following quarter), a 60% increase in Q2 2026 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 76.10K $7.43M New
Q4 2025 210.00K $20.02M Add
Q1 2026 795.55K $49.92M Add
Q2 2026 1.27M $54.22M Add
Q3 2026 550.00K $24.01M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 18 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.56B), MFS Investment Management (US$2.29B), Arrowstreet Capital (US$1.24B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has Prosight Management, LP held BSX?

Prosight Management, LP has disclosed BSX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Prosight Management, LP's current position in BSX?

As of Q3 2026, Prosight Management, LP holds 550.00K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $24.01M, representing 4.66% of its reported portfolio and ranking #7.

Has Prosight Management, LP been buying or selling BSX?

In the latest 13F filing (Q3 2026), Prosight Management, LP reduced its position in BSX. The position peaked in Q2 2026 at 1.27M shares.

Which other funds hold BSX?

Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, MFS Investment Management, Arrowstreet Capital, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.